文献速递眼底病与葡萄膜炎小儿眼科与斜弱视

基于三维光学相干断层扫描数据的早产儿视网膜病变视网膜变化整合可视化

Integrated Visualization Highlighting Retinal Changes in Retinopathy of Prematurity From 3-Dimensional Optical Coherence Tomography Data.
PubMed 文献 · JAMA Ophthalmol · 2022-01-01

该横断面观察性研究纳入BabySTEPS前瞻性研究中2名早产儿(胎龄24周和30周),利用研究用扫频源OCT在矫正胎龄36周时采集三维数据,通过叠加视网膜血管阴影视图和厚度图评估有或无早产儿视网膜病变(ROP)眼的视网膜血管与微解剖特征,发现整合可视化可补充血管异常和视网膜微解剖信息。

要点

  • 在发生1型ROP的早产儿中,视网膜血管阴影视图-OCT确认后极部血管扩张迂曲、分流及中心凹周围血管发育不完整,形成1区颞侧无血管视网膜切迹。
  • 厚度图显示不规则增厚与变薄区域,整合可视化勾勒出较厚血管化视网膜与较薄无血管中心凹的边界,以及上位弓状血管上方视网膜外新生血管。
  • 在无ROP(0期)的早产儿中,视网膜血管阴影视图-OCT显示后极部无异常血管表现,整合可视化显示中心凹圆顶状视网膜增厚,确认为黄斑水肿。

核心结论

  • 在BabySTEPS研究的2名早产儿中,ROP疾病过程中OCT三维可视化展示了关于视网膜血管和微解剖的补充信息,可能对临床医生有用。
  • OCT提供的这些额外细节未来可整合入基于人工智能分析的ROP筛查方法中。

研究设计与样本

  • 该研究为横断面观察性OCT报告,数据来自2016年7月设计的早产儿眼成像研究(BabySTEPS)前瞻性研究,在杜克健康重症监护新生儿病房进行。
  • 2018年12月至2019年8月期间纳入2名胎龄分别为24周和30周的早产儿,接受ROP筛查并在筛查访视时成像。
  • 分析矫正胎龄36周的数据,所用可视化方法开发于2020年9月至2021年5月。

主要发现

  • 在发生1型ROP的早产儿右眼中,视网膜血管阴影视图-OCT确认后极部血管扩张迂曲、分流及中心凹周围血管发育不完整,导致1区颞侧无血管视网膜切迹。
  • 厚度图显示不规则增厚和变薄区域,整合可视化勾勒出较厚血管化视网膜与较薄无血管中心凹的边界,以及上位弓状血管上方视网膜外新生血管。
  • 在无ROP(0期)的早产儿右眼中,视网膜血管阴影视图-OCT显示后极部无异常血管表现,整合可视化显示中心凹圆顶状视网膜增厚,确认为黄斑水肿。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Early diagnosis of plus disease is critical in the management of retinopathy of prematurity (ROP). However, there is substantial interexpert disagreement in the diagnosis of plus disease based on vascular changes alone. Information derived from optical coherence tomography (OCT) may help characterize the severity of vascular and structural abnormalities in ROP. OBJECTIVE: To describe integrated visualization of 3-dimensional (3-D) data from investigational swept-source OCT optimized to delineate retinal vascular and microanatomical features in eyes with and without ROP. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional, observational report of OCT was captured in the prospective Study of Eye Imaging in Preterm Infants (BabySTEPS) designed in July 2016 at the Duke Health Intensive Care Nursery. Between December 2018 and August 2019, 2 preterm infants born at 24 and 30 weeks' gestation were enrolled, underwent ROP screening, and were imaged at those screening visits. Data at 36 weeks' postmenstrual age were analyzed via this visualization developed between September 2020 and May 2021. MAIN OUTCOMES AND MEASURES: Superimposed en face retinal vascular shadow view (RVSV) montages and thickness maps were used along with OCT B-scans to evaluate retinal vasculature and cross-section in eyes with and without ROP. RESULTS: In the right eyes of 2 infants, 3-D data were integrated and visualized from investigational bedside OCT imaging at the posterior pole. In the infant who developed type 1 ROP, RVSV-OCT confirmed presence of dilated and tortuous posterior pole vessels, shunting, and incomplete perifoveal vascular development, resulting in a temporal notch of avascular retina in zone 1. The thickness map revealed irregular pockets of thickening and thinning, and integrated visualization outlined the demarcation between thicker vascularized retina and thinner avascular fovea and presence of extraretinal neovascularization overlying elevated vessels in the superior arcades. In the infant without ROP (stage 0), RVSV-OCT revealed no abnormal vascular findings at the posterior pole. The integrated visualization showed a dome-shaped retinal thickening at the fovea, which was confirmed as macular edema. CONCLUSIONS AND RELEVANCE: In 2 preterm infants in BabySTEPS, 3-D visualization of OCT findings during the ongoing ROP disease process demonstrated supplemental information about the retinal vasculature and microanatomy that can be useful to clinicians. These additional details provided by OCT could be integrated into future ROP screening methods with artificial intelligence-based analytics.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Mangalesh S, Seely KR, Tran-Viet D, et al. Integrated Visualization Highlighting Retinal Changes in Retinopathy of Prematurity From 3-Dimensional Optical Coherence Tomography Data. JAMA Ophthalmol. 2022. PMID: 35616956. doi:10.1001/jamaophthalmol.2022.1344

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。